May myo‐inositol and d ‐chiro‐inositol (40:1) treatment be a good option on normal‐weighted polycystic ovary syndrome patients without insulin resistance?-Reference-Cited by-同舟云学术

May myo‐inositol and d ‐chiro‐inositol (40:1) treatment be a good option on normal‐weighted polycystic ovary syndrome patients without insulin resistance?

Published:2020-09-28 Issue:12 Volume:46 Page:2605-2611
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Colak Eser¹^ORCID,Ozcimen Emel Ebru¹,Tohma Yusuf Aytac²,Ceran Mehmet Ufuk¹

Affiliation:

1. Department of Gynecology and Obstetrics Baskent University School of Medicine, Konya Medical and Research Center Konya Turkey

2. Department of Gynecology and Obstetrics Baskent University School of Medicine Ankara Turkey

Funder

Baskent Üniversitesi

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jog.14505

Reference22 articles.

1. Combining treatment with myo-inositol andD-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients

2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)

3. Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept;Orio F;Eur J Clin Nutr,2015

4. Drospirenone for the Treatment of Hirsute Women with Polycystic Ovary Syndrome: A Clinical, Endocrinological, Metabolic Pilot Study

5. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of surgical treatment of uterine myoma in women with obesity and the metabolic syndrome;REPRODUCTIVE ENDOCRINOLOGY;2023-03-27

2. Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome;Biomedicines;2022-06-02

3. Mitochondrial Dysfunction and Chronic Inflammation in Polycystic Ovary Syndrome;International Journal of Molecular Sciences;2021-04-10

4. Letter to “May myo‐inositol and D‐chiro‐inositol (40:1) treatment be a good option on normal‐weighted polycystic ovary syndrome patients without insulin resistance?”;Journal of Obstetrics and Gynaecology Research;2020-12-02